Sort
3,198 grants matching “mrna vaccine”
mRNA-Based Vaccines Against Tick Borne Thogotoviruses
$207,262Adrianus Cm Boon · Washington University · R21 · FY2025 · AI
Translational Control in Plasmodium Sexual Development
$207,180Pennsylvania State University-Univ Park · R01 · FY2005 · AI
Project 3: Dr. Li
$206,648Jianrong Li · Research Inst Nationwide Children'S Hosp · P01 · FY2019 · AI
A Transgenic Mouse Model to Study Ebolaviruses and other Filoviruses
$206,568Yoshihiro Kawaoka · University Of Wisconsin-Madison · R21 · FY2020 · AI
Pre-clinical evaluation of alpha-Cache; a novel RNA vaccine for an emerging orthobunyavirus
$206,342Albert J. Auguste · Virginia Polytechnic Inst And St Univ · R21 · FY2024 · AI
Project 3: Dr. Li
$206,315Jianrong Li · Research Inst Nationwide Children'S Hosp · P01 · FY2018 · AI
Gonococcal In-vivo Expressed Factors (IVEFs) as novel vaccine antigens against N. gonorrhoeae infection
$206,250Paola Massari · Tufts University Boston · R21 · FY2018 · AI
Activation of STING-mediated pathway(s) in T cells
$206,250Alexander Poltorak · Tufts University Boston · R21 · FY2016 · AI
Identifying target antigens for Cryptosporidium vaccine
$206,250Saul R Tzipori · Tufts University Boston · R21 · FY2021 · AI
Determining the impact of respiratory syncytial virus M2-1 protein on post-transcriptional regulation of cellular and viral mRNAs
$206,250Rachel Fearns · Boston University Medical Campus · R21 · FY2024 · AI
RNA encoded nanobody-based immunotherapeutics targeting essential, host-interactive schistosome ectoenzymes
$206,250Patrick J Skelly · Tufts University Boston · R21 · FY2024 · AI
Toward synthetic chemically defined mRNA for human therapeutics
$205,541Keith Thomas Gagnon · Wake Forest University Health Sciences · R21 · FY2023 · GM
Identifying Chlamydia trachomatis factors that mediate PD-L1 upregulation
$205,449Michael N Starnbach · Harvard Medical School · R21 · FY2024 · AI
NORMAL/UV INDUCED ANTIGEN PRESENTING CELLS
$205,326Case Western Reserve University · R01 · FY2001 · AI
Peptide-vaccine development against Lyme disease Supplement
$204,972Mariette Barbier · West Virginia University · R01 · FY2022 · AI
A Non-Viral Genetic Vaccine for Prevention and Treatment of Multiple Sclerosis
$204,688Jordan Green · Johns Hopkins University · R21 · FY2021 · AI
mRNA vaccine responses in PLWH
$204,688Joel N Blankson · Johns Hopkins University · R21 · FY2023 · AI
Regulation of Humoral Immunity by SR Protein Kinase 3
$204,583James R Hagman · National Jewish Health · R21 · FY2019 · AI
Cellular auto-immune mechanisms of narcolepsy
$204,173Igor J Koralnik · Rush University Medical Center · R21 · FY2017 · NS
Animal Core
$203,809Barton F Haynes · Duke University · U19 · FY2020 · AI
Impact of Fluoroquinolone resistance on Pseudomonas virulence and patient outcome
$203,750Annie Wong-Beringer · University Of Southern California · R21 · FY2008 · AI
SARS-CoV-2 in Pregnancy: Comparison of Natural Infection and Hybrid Immunity in Mother-Infant Pairs
$203,580Mary Catherine Cambou · University Of California Los Angeles · K23 · FY2024 · AI
SARS-CoV-2 in Pregnancy: Comparison of Natural Infection and Hybrid Immunity in Mother-Infant Pairs
$203,580Mary Catherine Cambou · University Of California Los Angeles · K23 · FY2023 · AI
SARS-CoV-2 in Pregnancy: Comparison of Natural Infection and Hybrid Immunity in Mother-Infant Pairs
$203,580Mary Catherine Cambou · University Of California Los Angeles · K23 · FY2025 · AI
Impact of Fluoroquinolone resistance on Pseudomonas virulence and patient outcome
$203,541Annie Wong-Beringer · University Of Southern California · R21 · FY2009 · AI